Inhibrx Biosciences, Inc. carries a market capitalization of 225.87M, placing it among publicly traded companies globally.
| Market Cap | 225.87M |
| Enterprise Value | N/A |
Inhibrx Biosciences, Inc.'s stock has gained approximately 13.93678% over the past 52 weeks. The 50-day moving average sits at 16.45, while the 200-day moving average is 16.45.
| Beta (5Y) | N/A |
| 52-Week Price Change | 13.93678% |
| 50-Day Moving Average | 16.45 |
| 200-Day Moving Average | 16.45 |
| Average Volume (20 Days) | N/A |